-
1
-
-
67349133489
-
Protecting the blood supply from emerging pathogens: the role of pathogen inactivation
-
Blajchman M.A. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Clin Biol 2009, 16:70-74.
-
(2009)
Transfus Clin Biol
, vol.16
, pp. 70-74
-
-
Blajchman, M.A.1
-
2
-
-
84866851104
-
Emerging pathogens and their implications for the blood supply and transfusion transmitted infections
-
Dodd R.Y. Emerging pathogens and their implications for the blood supply and transfusion transmitted infections. Br J Haematol 2012, 159:135-142.
-
(2012)
Br J Haematol
, vol.159
, pp. 135-142
-
-
Dodd, R.Y.1
-
3
-
-
84882918127
-
Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
-
Breban R., Riou J., Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 2013, 382:694-699.
-
(2013)
Lancet
, vol.382
, pp. 694-699
-
-
Breban, R.1
Riou, J.2
Fontanet, A.3
-
4
-
-
0038690593
-
Treatment of severe acute respiratory syndrome with convalescent plasma
-
Wong V.W., Dai D., Wu A.K., Sung J.J. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J 2003, 9:199-201.
-
(2003)
Hong Kong Med J
, vol.9
, pp. 199-201
-
-
Wong, V.W.1
Dai, D.2
Wu, A.K.3
Sung, J.J.4
-
5
-
-
33845609269
-
Successful treatment of avian influenza with convalescent plasma
-
Kong L.K., Zhou B.P. Successful treatment of avian influenza with convalescent plasma. Hong Kong Med J 2006, 12:489.
-
(2006)
Hong Kong Med J
, vol.12
, pp. 489
-
-
Kong, L.K.1
Zhou, B.P.2
-
6
-
-
77953085882
-
Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product?
-
Leider J.P., Brunker P.A., Ness P.M. Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product?. Transfusion 2010, 50:1384-1398.
-
(2010)
Transfusion
, vol.50
, pp. 1384-1398
-
-
Leider, J.P.1
Brunker, P.A.2
Ness, P.M.3
-
7
-
-
33644685030
-
Convalescent whole blood, plasma and serum in the prophylaxis of measles: JAMA, 12 April, 1926; 1180-1187
-
discussion 18-21
-
Zingher A., Mortimer P. Convalescent whole blood, plasma and serum in the prophylaxis of measles: JAMA, 12 April, 1926; 1180-1187. Rev Med Virol 2005, 15:407-418. discussion 18-21.
-
(2005)
Rev Med Virol
, vol.15
, pp. 407-418
-
-
Zingher, A.1
Mortimer, P.2
-
8
-
-
33750721332
-
Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?
-
Luke T.C., Kilbane E.M., Jackson J.L., Hoffman S.L. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?. Ann Intern Med 2006, 145:599-609.
-
(2006)
Ann Intern Med
, vol.145
, pp. 599-609
-
-
Luke, T.C.1
Kilbane, E.M.2
Jackson, J.L.3
Hoffman, S.L.4
-
9
-
-
84967899788
-
Convalescent serum in prophylaxis of measles, chicken-pox, and mumps
-
Gunn W. Convalescent serum in prophylaxis of measles, chicken-pox, and mumps. Br Med J 1932, 1:183-185.
-
(1932)
Br Med J
, vol.1
, pp. 183-185
-
-
Gunn, W.1
-
12
-
-
84908140458
-
First Ebola treatment is approved by WHO
-
Gulland A. First Ebola treatment is approved by WHO. Br Med J 2014, 349:g5539.
-
(2014)
Br Med J
, vol.349
, pp. g5539
-
-
Gulland, A.1
-
13
-
-
0033062193
-
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee
-
Mupapa K., Massamba M., Kibadi K., et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis 1999, 179(Suppl. 1):S18-S23.
-
(1999)
J Infect Dis
, vol.179
, pp. S18-S23
-
-
Mupapa, K.1
Massamba, M.2
Kibadi, K.3
-
14
-
-
0017737552
-
A case of Ebola virus infection
-
Emond R., Evans B., Bowen E., Lloyd G. A case of Ebola virus infection. Br Med J 1977, 2:541.
-
(1977)
Br Med J
, vol.2
, pp. 541
-
-
Emond, R.1
Evans, B.2
Bowen, E.3
Lloyd, G.4
-
15
-
-
0036100307
-
Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody
-
Parren P.W., Geisbert T.W., Maruyama T., Jahrling P.B., Burton D.R. Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J Virol 2002, 76:6408-6412.
-
(2002)
J Virol
, vol.76
, pp. 6408-6412
-
-
Parren, P.W.1
Geisbert, T.W.2
Maruyama, T.3
Jahrling, P.B.4
Burton, D.R.5
-
16
-
-
79959850960
-
Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus
-
Macneil A., Reed Z., Rollin P.E. Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. PLoS Negl Trop Dis 2011, 5:e1175.
-
(2011)
PLoS Negl Trop Dis
, vol.5
-
-
Macneil, A.1
Reed, Z.2
Rollin, P.E.3
-
17
-
-
38449108626
-
Epitopes required for antibody-dependent enhancement of Ebola virus infection
-
Takada A., Ebihara H., Feldmann H., Geisbert T.W., Kawaoka Y. Epitopes required for antibody-dependent enhancement of Ebola virus infection. J Infect Dis 2007, 196(Suppl. 2):S347-S356.
-
(2007)
J Infect Dis
, vol.196
, pp. S347-S356
-
-
Takada, A.1
Ebihara, H.2
Feldmann, H.3
Geisbert, T.W.4
Kawaoka, Y.5
-
18
-
-
0038467640
-
Antibody-dependent enhancement of Ebola virus infection
-
Takada A., Feldmann H., Ksiazek T.G., Kawaoka Y. Antibody-dependent enhancement of Ebola virus infection. J Virol 2003, 77:7539-7544.
-
(2003)
J Virol
, vol.77
, pp. 7539-7544
-
-
Takada, A.1
Feldmann, H.2
Ksiazek, T.G.3
Kawaoka, Y.4
-
19
-
-
0036348849
-
Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections
-
Geisbert T.W., Hensley L.E., Geisbert J.B., Jahrling P.B. Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections. Virology 2002, 293:15-19.
-
(2002)
Virology
, vol.293
, pp. 15-19
-
-
Geisbert, T.W.1
Hensley, L.E.2
Geisbert, J.B.3
Jahrling, P.B.4
-
20
-
-
84875537661
-
The use of convalescent human serum in influenza pneumonia-a preliminary report
-
McGuire L.W., Redden W.R. The use of convalescent human serum in influenza pneumonia-a preliminary report. Am J Public Health 1918, 8:741-744.
-
(1918)
Am J Public Health
, vol.8
, pp. 741-744
-
-
McGuire, L.W.1
Redden, W.R.2
-
21
-
-
84864021934
-
Strategies for screening blood donors to source convalescent H1N1v plasma for intervention therapy
-
Parry R.P., Tettmar K.I., Hoschler K., et al. Strategies for screening blood donors to source convalescent H1N1v plasma for intervention therapy. Vox Sang 2012, 103:107-112.
-
(2012)
Vox Sang
, vol.103
, pp. 107-112
-
-
Parry, R.P.1
Tettmar, K.I.2
Hoschler, K.3
-
22
-
-
84922618669
-
Convalescent blood for herpes zoster
-
Gundersen T. Convalescent blood for herpes zoster. Trans Am Ophthalmol Soc 1935, 33:508-520.
-
(1935)
Trans Am Ophthalmol Soc
, vol.33
, pp. 508-520
-
-
Gundersen, T.1
-
23
-
-
84922657925
-
The 1934 Epidemic of poliomyelitis in Denmark. Preliminary report on the epidemiology, clinical features and convalescent serum therapy: (section of pathology)
-
Jensen C. The 1934 Epidemic of poliomyelitis in Denmark. Preliminary report on the epidemiology, clinical features and convalescent serum therapy: (section of pathology). Proc R Soc Med 1935, 28:1007-1026.
-
(1935)
Proc R Soc Med
, vol.28
, pp. 1007-1026
-
-
Jensen, C.1
-
24
-
-
84922676086
-
Treatment of typhoid fever with convalescent whole blood
-
Dewar H.A. Treatment of typhoid fever with convalescent whole blood. J R Army Med Corps 1946, 86:249-253.
-
(1946)
J R Army Med Corps
, vol.86
, pp. 249-253
-
-
Dewar, H.A.1
-
25
-
-
84922678267
-
Convalescent serum in prophylaxis of measles
-
Nabarro D.N., Signy A.G. Convalescent serum in prophylaxis of measles. Br Med J 1931, 1:12-13.
-
(1931)
Br Med J
, vol.1
, pp. 12-13
-
-
Nabarro, D.N.1
Signy, A.G.2
-
26
-
-
0018377394
-
The prevention of chickenpox in high risk children. Comparison of the effectiveness of specific immunoglobulins and of defibrinated convalescent plasma. 414 cases (author's transl)
-
Avenard G., Gaiffe M., Herzog F. The prevention of chickenpox in high risk children. Comparison of the effectiveness of specific immunoglobulins and of defibrinated convalescent plasma. 414 cases (author's transl). Nouv Presse Med 1979, 8:673-675.
-
(1979)
Nouv Presse Med
, vol.8
, pp. 673-675
-
-
Avenard, G.1
Gaiffe, M.2
Herzog, F.3
-
27
-
-
77956324536
-
Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection
-
Wong H.K., Lee C.K., Hung I.F., et al. Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection. Transfusion 2010, 50:1967-1971.
-
(2010)
Transfusion
, vol.50
, pp. 1967-1971
-
-
Wong, H.K.1
Lee, C.K.2
Hung, I.F.3
-
28
-
-
0018614142
-
Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome
-
Maiztegui J.I., Fernandez N.J., de Damilano A.J. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 1979, 2:1216-1217.
-
(1979)
Lancet
, vol.2
, pp. 1216-1217
-
-
Maiztegui, J.I.1
Fernandez, N.J.2
de Damilano, A.J.3
-
29
-
-
19944433718
-
Use of convalescent plasma therapy in SARS patients in Hong Kong
-
Cheng Y., Wong R., Soo Y.O., et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 2005, 24:44-46.
-
(2005)
Eur J Clin Microbiol Infect Dis
, vol.24
, pp. 44-46
-
-
Cheng, Y.1
Wong, R.2
Soo, Y.O.3
-
30
-
-
84908289137
-
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis
-
pii: jiu396
-
Mair-Jenkins J., Saavedra-Campos M., Baillie J.K., et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 2014, pii: jiu396.
-
(2014)
J Infect Dis
-
-
Mair-Jenkins, J.1
Saavedra-Campos, M.2
Baillie, J.K.3
-
31
-
-
4043134495
-
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
-
Soo Y.O., Cheng Y., Wong R., et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect 2004, 10:676-678.
-
(2004)
Clin Microbiol Infect
, vol.10
, pp. 676-678
-
-
Soo, Y.O.1
Cheng, Y.2
Wong, R.3
-
32
-
-
27744600001
-
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
-
Yeh K.M., Chiueh T.S., Siu L.K., et al. Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital. J Antimicrob Chemother 2005, 56:919-922.
-
(2005)
J Antimicrob Chemother
, vol.56
, pp. 919-922
-
-
Yeh, K.M.1
Chiueh, T.S.2
Siu, L.K.3
-
33
-
-
79951821842
-
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection
-
Hung I.F., To K.K., Lee C.K., et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 2011, 52:447-456.
-
(2011)
Clin Infect Dis
, vol.52
, pp. 447-456
-
-
Hung, I.F.1
To, K.K.2
Lee, C.K.3
-
34
-
-
34948813121
-
Treatment with convalescent plasma for influenza A (H5N1) infection
-
Zhou B., Zhong N., Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 2007, 357:1450-1451.
-
(2007)
N Engl J Med
, vol.357
, pp. 1450-1451
-
-
Zhou, B.1
Zhong, N.2
Guan, Y.3
-
35
-
-
0021154495
-
The use of Lassa fever convalescent plasma in Nigeria
-
Frame J.D., Verbrugge G.P., Gill R.G., Pinneo L. The use of Lassa fever convalescent plasma in Nigeria. Trans R Soc Trop Med Hyg 1984, 78:319-324.
-
(1984)
Trans R Soc Trop Med Hyg
, vol.78
, pp. 319-324
-
-
Frame, J.D.1
Verbrugge, G.P.2
Gill, R.G.3
Pinneo, L.4
-
36
-
-
84941325516
-
Methylene blue/light treatment of virus inactivated human plasma: production and clinical experience
-
Mohr H., Pohl U., Lambrecht B., Wieding J.U., Schmitt H. Methylene blue/light treatment of virus inactivated human plasma: production and clinical experience. Infusionsther Transfusionsmed 1993, 20(Suppl. 2):19-24.
-
(1993)
Infusionsther Transfusionsmed
, vol.20
, pp. 19-24
-
-
Mohr, H.1
Pohl, U.2
Lambrecht, B.3
Wieding, J.U.4
Schmitt, H.5
-
37
-
-
33746572800
-
Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function
-
Singh Y., Sawyer L.S., Pinkoski L.S., et al. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 2006, 46:1168-1177.
-
(2006)
Transfusion
, vol.46
, pp. 1168-1177
-
-
Singh, Y.1
Sawyer, L.S.2
Pinkoski, L.S.3
-
38
-
-
74549226197
-
Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C
-
Bihm D.J., Ettinger A., Buytaert-Hoefen K.A., et al. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C. Vox Sang 2010, 98:108-115.
-
(2010)
Vox Sang
, vol.98
, pp. 108-115
-
-
Bihm, D.J.1
Ettinger, A.2
Buytaert-Hoefen, K.A.3
-
39
-
-
14844293483
-
Pathogen inactivation technology: cleansing the blood supply
-
Klein H.G. Pathogen inactivation technology: cleansing the blood supply. J Intern Med 2005, 257:224-237.
-
(2005)
J Intern Med
, vol.257
, pp. 224-237
-
-
Klein, H.G.1
-
40
-
-
78651284022
-
A comparison of methods of pathogen inactivation of FFP
-
Rock G. A comparison of methods of pathogen inactivation of FFP. Vox Sang 2011, 100:169-178.
-
(2011)
Vox Sang
, vol.100
, pp. 169-178
-
-
Rock, G.1
-
41
-
-
33748475913
-
Update on pathogen reduction technology for therapeutic plasma: an overview
-
Solheim B.G., Seghatchian J. Update on pathogen reduction technology for therapeutic plasma: an overview. Transfus Apher Sci 2006, 35:83-90.
-
(2006)
Transfus Apher Sci
, vol.35
, pp. 83-90
-
-
Solheim, B.G.1
Seghatchian, J.2
-
42
-
-
74049149907
-
Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system
-
El-Ekiaby M., Sayed M.A., Caron C., et al. Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system. Transfus Med 2010, 20:48-61.
-
(2010)
Transfus Med
, vol.20
, pp. 48-61
-
-
El-Ekiaby, M.1
Sayed, M.A.2
Caron, C.3
-
43
-
-
0033675858
-
Virucidal heat-treatment of single plasma units: a potential approach for developing countries
-
Goubran H.A., Burnouf T., Radosevich M. Virucidal heat-treatment of single plasma units: a potential approach for developing countries. Haemophilia 2000, 6:597-604.
-
(2000)
Haemophilia
, vol.6
, pp. 597-604
-
-
Goubran, H.A.1
Burnouf, T.2
Radosevich, M.3
-
44
-
-
0035179498
-
Passive transfer of scrub typhus plasma to patients with AIDS: a descriptive clinical study
-
Watt G., Kantipong P., Jongsakul K., de Souza M., Burnouf T. Passive transfer of scrub typhus plasma to patients with AIDS: a descriptive clinical study. QJM 2001, 94:599-607.
-
(2001)
QJM
, vol.94
, pp. 599-607
-
-
Watt, G.1
Kantipong, P.2
Jongsakul, K.3
de Souza, M.4
Burnouf, T.5
-
45
-
-
0034609287
-
HIV-1 suppression during acute scrub-typhus infection
-
Watt G., Kantipong P., de Souza M., et al. HIV-1 suppression during acute scrub-typhus infection. Lancet 2000, 356:475-479.
-
(2000)
Lancet
, vol.356
, pp. 475-479
-
-
Watt, G.1
Kantipong, P.2
de Souza, M.3
-
46
-
-
0026536771
-
Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma
-
Vittecoq D., Mattlinger B., Barre-Sinoussi F., et al. Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. J Infect Dis 1992, 165:364-368.
-
(1992)
J Infect Dis
, vol.165
, pp. 364-368
-
-
Vittecoq, D.1
Mattlinger, B.2
Barre-Sinoussi, F.3
-
47
-
-
0028893431
-
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma
-
Vittecoq D., Chevret S., Morand-Joubert L., et al. Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma. Proc Natl Acad Sci U S A 1995, 92:1195-1199.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 1195-1199
-
-
Vittecoq, D.1
Chevret, S.2
Morand-Joubert, L.3
-
48
-
-
0038666249
-
Nanofiltration of single plasma donations: feasibility study
-
Burnouf T., Radosevich M., El-Ekiaby M., et al. Nanofiltration of single plasma donations: feasibility study. Vox Sang 2003, 84:111-119.
-
(2003)
Vox Sang
, vol.84
, pp. 111-119
-
-
Burnouf, T.1
Radosevich, M.2
El-Ekiaby, M.3
-
49
-
-
79851505483
-
New methods of plasma fractionation - a presentation of the 'mini-pool' fractionation procedure developed in Egypt
-
State of the Art Presentations
-
El-Ekiaby M., Radosevich M., Goubran H., El Sayed M., Burnouf T. New methods of plasma fractionation - a presentation of the 'mini-pool' fractionation procedure developed in Egypt. ISBT Science Series 2009, 4(1):99-106. State of the Art Presentations.
-
(2009)
ISBT Science Series
, vol.4
, Issue.1
, pp. 99-106
-
-
El-Ekiaby, M.1
Radosevich, M.2
Goubran, H.3
El Sayed, M.4
Burnouf, T.5
-
50
-
-
0036628384
-
Inactivation of lipid enveloped viruses by octanoic acid treatment of immunoglobulin solution
-
Dichtelmuller H., Rudnick D., Kloft M. Inactivation of lipid enveloped viruses by octanoic acid treatment of immunoglobulin solution. Biologicals 2002, 30:135-142.
-
(2002)
Biologicals
, vol.30
, pp. 135-142
-
-
Dichtelmuller, H.1
Rudnick, D.2
Kloft, M.3
-
51
-
-
0036628331
-
Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates
-
Korneyeva M., Hotta J., Lebing W., Rosenthal R.S., Franks L., Petteway S.R. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates. Biologicals 2002, 30:153-162.
-
(2002)
Biologicals
, vol.30
, pp. 153-162
-
-
Korneyeva, M.1
Hotta, J.2
Lebing, W.3
Rosenthal, R.S.4
Franks, L.5
Petteway, S.R.6
-
52
-
-
84922624376
-
Clinical evaluation of minipool immunoglobulin plasma fraction in primary immunodeficiency patients. 5A-S42-02
-
El-Ekiaby M., Burnouf T., El-Marsafy A., Galal N., Goubran H., Radosevic M. Clinical evaluation of minipool immunoglobulin plasma fraction in primary immunodeficiency patients. 5A-S42-02. Vox Sang 2014, 107:1-56.
-
(2014)
Vox Sang
, vol.107
, pp. 1-56
-
-
El-Ekiaby, M.1
Burnouf, T.2
El-Marsafy, A.3
Galal, N.4
Goubran, H.5
Radosevic, M.6
-
53
-
-
84991490033
-
Pathogen Inactivation
-
Wiley-Blackwell, Oxford, UK, T.L. Simon, E.L. Snyder, B.G. Solheim, C.P. Stowell, R.G. Strauss, M. Petrides (Eds.)
-
Solheim BG, Seghatchian J Pathogen Inactivation. Rossi's Principles of Transfusion Medicine 2009, Wiley-Blackwell, Oxford, UK. 4th ed, 10.1002/9781444303513.ch51. T.L. Simon, E.L. Snyder, B.G. Solheim, C.P. Stowell, R.G. Strauss, M. Petrides (Eds.).
-
(2009)
Rossi's Principles of Transfusion Medicine
-
-
Solheim, B.G.1
Seghatchian, J.2
-
55
-
-
33846666175
-
Modern plasma fractionation
-
Burnouf T. Modern plasma fractionation. Transfus Med Rev 2007, 21:101-117.
-
(2007)
Transfus Med Rev
, vol.21
, pp. 101-117
-
-
Burnouf, T.1
-
56
-
-
73649119908
-
Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance
-
Radosevich M., Burnouf T. Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance. Vox Sang 2010, 98:12-28.
-
(2010)
Vox Sang
, vol.98
, pp. 12-28
-
-
Radosevich, M.1
Burnouf, T.2
-
57
-
-
84922614431
-
Annex 4. Recommendations for the collection, quality control and regulation of human plasma for fractionation
-
WHO Annex 4. Recommendations for the collection, quality control and regulation of human plasma for fractionation. WHO Tech Rep Ser 2007, 941:189-264.
-
(2007)
WHO Tech Rep Ser
, vol.941
, pp. 189-264
-
-
-
58
-
-
0025953526
-
Parasitological and clinical human response to immunoglobulin administration in falciparum-malaria
-
Sabchareon A., Burnouf T., Ouattara D., et al. Parasitological and clinical human response to immunoglobulin administration in falciparum-malaria. Am J Trop Med Hyg 1991, 45:297-308.
-
(1991)
Am J Trop Med Hyg
, vol.45
, pp. 297-308
-
-
Sabchareon, A.1
Burnouf, T.2
Ouattara, D.3
-
59
-
-
21644441263
-
Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma
-
Zhang Z., Xie Y.W., Hong J., et al. Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma. Transfusion 2005, 45:1160-1164.
-
(2005)
Transfusion
, vol.45
, pp. 1160-1164
-
-
Zhang, Z.1
Xie, Y.W.2
Hong, J.3
-
60
-
-
34447649014
-
West Nile virus neutralization by US plasma-derived immunoglobulin products
-
Planitzer C.B., Modrof J., Kreil T.R. West Nile virus neutralization by US plasma-derived immunoglobulin products. J Infect Dis 2007, 196:435-440.
-
(2007)
J Infect Dis
, vol.196
, pp. 435-440
-
-
Planitzer, C.B.1
Modrof, J.2
Kreil, T.R.3
-
61
-
-
79952636467
-
Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010
-
Rabel P.O., Planitzer C.B., Farcet M.R., et al. Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010. Euro Surveill 2011, 16.
-
(2011)
Euro Surveill
, vol.16
-
-
Rabel, P.O.1
Planitzer, C.B.2
Farcet, M.R.3
-
62
-
-
73349105246
-
Hepatitis A virus antibodies in immunoglobulin preparations
-
Farcet M.R., Planitzer C.B., Stein O., Modrof J., Kreil T.R. Hepatitis A virus antibodies in immunoglobulin preparations. J Allergy Clin Immunol 2010, 125:198-202.
-
(2010)
J Allergy Clin Immunol
, vol.125
, pp. 198-202
-
-
Farcet, M.R.1
Planitzer, C.B.2
Stein, O.3
Modrof, J.4
Kreil, T.R.5
-
63
-
-
33748422647
-
Measles-virus-neutralizing antibodies in intravenous immunoglobulins
-
Audet S., Virata-Theimer M.L., Beeler J.A., et al. Measles-virus-neutralizing antibodies in intravenous immunoglobulins. J Infect Dis 2006, 194:781-789.
-
(2006)
J Infect Dis
, vol.194
, pp. 781-789
-
-
Audet, S.1
Virata-Theimer, M.L.2
Beeler, J.A.3
-
64
-
-
84908150231
-
Ebola: a call for blood transfusion strategy in sub-Saharan Africa
-
Burnouf T., Emmanuel J., Mbanya D., et al. Ebola: a call for blood transfusion strategy in sub-Saharan Africa. Lancet 2014, 384:1347-1348.
-
(2014)
Lancet
, vol.384
, pp. 1347-1348
-
-
Burnouf, T.1
Emmanuel, J.2
Mbanya, D.3
|